Rimka Pharma SRL
Rimka Pharma reported total assets of €1.80m at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026).
The score of Rimka Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1 % Total assets +26 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rimka Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Rimka Pharma's financial analysis
- Solvency59.4%sector median: 53.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rimka Pharma
Rimka Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0885.476.178
- VAT number
- BE0885476178
- Peppol
- Registered · 0208:0885476178 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Dec 2006
- Registered office
- 2630 Aartselaar
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Activities of head offices (NACE 7010001)
Rimka Pharma (SRL) has been based in Aartselaar since 2006, active in: activities of head offices. For 2025, it reports a net profit of 11,153 € and equity of €1.07m; its revenue is not published. Its solvency stands at 59.4%, above the median of its sector (53.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Rimka Pharma
Companies in the same business, of comparable size and area, outside its group.
- Kantoor L. Stevens Fund management activities Aarschot · balance sheet €1.80m
- Jamar-GAS Activities of holding companies Wommelgem · balance sheet €1.80m
- Majual Activities of holding companies Ciney · balance sheet €1.80m
- Belgoteam Installation of insulation Flémalle · balance sheet €1.80m
- Immobilière de l'Abbaye Temse · balance sheet €1.80m
- VdG Tenbosch Activities of holding companies Ixelles · balance sheet €1.80m
- Den Duts Rental and operating of own or leased real estate Schilde · balance sheet €1.80m
- Malysse Invest Beernem · balance sheet €1.80m
Frequently asked questions about Rimka Pharma
What is the revenue of Rimka Pharma?
Rimka Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rimka Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0885476178 for Rimka Pharma, if the company is VAT-registered. Its company number (CBE) is 0885.476.178.
Where is the registered office of Rimka Pharma?
According to the CBE register, the registered office of Rimka Pharma is in 2630 Aartselaar.
What is the equity of Rimka Pharma?
At the close of the 2025 financial year, the equity of Rimka Pharma amounts to 1,071,597 €, a solvency of 59.4% of total assets.
Who manages Rimka Pharma?
The register lists 2 active mandates at Rimka Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Rimka Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →